GenScript Biotech Corporation has issued a positive profit alert, indicating an expected increase in profitability for the upcoming reporting period. The announcement, made by the company's Chairman and Executive Director, Robin Meng, is based on a preliminary assessment of the company's latest unaudited management accounts. This potential increase in profit is subject to finalization and potential adjustments, as the figures have not yet been audited or reviewed by the company's auditor. Shareholders and potential investors are advised to await the interim results announcement, expected before the end of August 2025, and to exercise caution when dealing with the company's shares.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.